healthFDA Approves Bristol Myers Squibb's Cobenfy, Marking First New Class of Schizophrenia Drug in 70 Years
The FDA has approved Cobenfy, the first fundamentally new pharmacological treatment for schizophrenia in over seven decades, offering transformative hope to millions of psychiatric patients.
